Semi-Annual Statement Of Income

Fuso Pharmaceutical Industries,Ltd. - Filing #7599190

Concept 2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
Semi-annual statement of income
Statement of income
Net sales
49,632,000,000 JPY
49,251,000,000 JPY
Cost of sales
36,235,000,000 JPY
35,142,000,000 JPY
Ordinary profit (loss)
1,996,000,000 JPY
2,227,000,000 JPY
Gross profit (loss)
13,397,000,000 JPY
14,109,000,000 JPY
Extraordinary income
JPY
129,000,000 JPY
Selling, general and administrative expenses
11,473,000,000 JPY
11,760,000,000 JPY
Extraordinary losses
85,000,000 JPY
11,000,000 JPY
Selling, general and administrative expenses
Salaries
2,430,000,000 JPY
2,437,000,000 JPY
Depreciation
487,000,000 JPY
487,000,000 JPY
Profit (loss) before income taxes
1,911,000,000 JPY
2,345,000,000 JPY
Operating profit (loss)
1,924,000,000 JPY
2,351,000,000 JPY
Non-operating income
376,000,000 JPY
213,000,000 JPY
Income taxes - current
410,000,000 JPY
745,000,000 JPY
Income taxes - deferred
17,000,000 JPY
-7,000,000 JPY
Non-operating income
Income taxes
427,000,000 JPY
737,000,000 JPY
Non-operating expenses
304,000,000 JPY
336,000,000 JPY
Profit (loss)
1,483,000,000 JPY
1,483,000,000 JPY
1,483,000,000 JPY
1,483,000,000 JPY
1,607,000,000 JPY
1,607,000,000 JPY
1,607,000,000 JPY
1,607,000,000 JPY
Non-operating expenses
Interest expenses
176,000,000 JPY
196,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
JPY
91,000,000 JPY
Extraordinary losses

Talk to a Data Expert

Have a question? We'll get back to you promptly.